Abstract

Autoimmunity increases with aging indicative of reduced immune tolerance, but the mechanisms involved are poorly defined. In recent years, subsets of B cells with immunoregulatory properties have been identified in murine models of autoimmune disorders, and these cells downregulate immune responses via secretion of IL10. In humans, immature transitional B cells with a CD19+CD24hiCD38hi phenotype have been reported to regulate immune responses via IL10 production. We found the frequency and numbers of CD19+CD24hiCD38hi cells were reduced in the PBMC pool with age. IL10 expression and secretion following activation via either CD40, or Toll-like receptors was also impaired in CD19+CD24hiCD38hi B cells from healthy older donors. When investigating the mechanisms involved, we found that CD19+CD24hiCD38hi B-cell function was compromised by age-related effects on both T cells and B cells: specifically, CD40 ligand expression was lower in CD4 T cells from older donors following CD3 stimulation, and signalling through CD40 was impaired in CD19+CD24hiCD38hi B cells from elders as evidenced by reduced phosphorylation (Y705) and activation of STAT3. However, there was no age-associated change in expression of costimulatory molecules CD80 and CD86 on CD19+CD24hiCD38hi cells, suggesting IL10-dependent immune suppression is impaired, but contact-dependent suppressive capacity is intact with age. Finally, we found a negative correlation between CD19+CD24hiCD38hi B-cell IL10 production and autoantibody (Rheumatoid factor) levels in older adults. We therefore propose that an age-related decline in CD19+CD24hiCD38hi B cell number and function may contribute towards the increased autoimmunity and reduced immune tolerance seen with aging.

Highlights

  • B cells have been shown to play a pathogenic role in human autoimmune diseases due to their ability to secrete autoantibodies and serve as antigen-presenting cells to T cells (Yanaba et al, 2008b)

  • Immature transitional CD19 +CD24hiCD38hi B cells have been reported to comprise the highest percentage of IL10-producing B cells upon CD40 stimulation (Blair et al, 2010)

  • Peripheral blood mononuclear cells (PBMC) isolated from young and older subjects were stimulated for 72 h with anti-CD3 antibody prior to immunostaining for the expression of CD19, CD24, CD38 and IL10 in order to identify B cells with regulatory properties (Blair et al, 2010)

Read more

Summary

Introduction

B cells have been shown to play a pathogenic role in human autoimmune diseases due to their ability to secrete autoantibodies and serve as antigen-presenting cells to T cells (Yanaba et al, 2008b). B cells can play both protective and pathogenic roles in the same pathological setting. Since a subset of B cells with immunosuppressive properties have been isolated and shown to suppress inflammation in a number of murine models of chronic inflammation, including collagen-induced arthritis (CIA), experimental autoimmune encephalitis (EAE) and inflammatory bowel disease (Mauri & Bosma, 2012). Two phenotypically distinct subsets of B cells: transitional CD19+CD24hiCD38hi B cells (Blair et al, 2010) and CD19+CD5+CD1dhi ‘B10’ B cells (Yanaba et al, 2008a) have been demonstrated to exert immunosuppressive functions. An additional B-cell subset of CD24hi CD27+ B cells, with 60% of these cells expressing CD38, has been identified with characteristics similar to mouse B10 cells (Iwata et al, 2011)

Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call